Adnan Ekinci
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Adnan Ekinci has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Muge Ozcan
Ankara Numune Education and Research Hospital, Otorhinolaryngology Clinic , Ankara , Turkey
3 shared publicationsEmre Demir
Hitit University School of Medicine , Department of Biostatistics , Corum , Turkey
2 shared publications- Hakan Dağıstan
Bozok University, Faculty of Medicine, Department of Otorhinolaryngology, Yozgat, TÜRKİYE
2 shared publications - Kaan Kamasak
SAĞLIK BAKANLIĞI
2 shared publications Abdurrahman Yetis
Department of Otorhinolaryngology, Hitit University School of Medicine, Çorum, Turkey
1 shared publicationAbdurrahman Yetiş
Department of Otorhinolaryngology Head and Neck Surgery, Hitit University, üctutlar mah.ahcılar 16.sokak. Ada apt.10/15, 19000, Corum, Turkey
1 shared publication
Latest Publications
- 1 April 2026
- Published by Modestum Ltd in Journal of Clinical and Experimental Investigations
- Vol. 17 (2) , em00859
Investigation of serum prolidase enzyme levels in patients with adenotonsillar hypertrophy
Objective: We investigated serum prolidase enzyme activity (SPEA) in patients with adenotonsillar hypertrophy (ATH) and compared the results with those of healthy children. We determined the enzyme levels again after adenotonsillectomy in the patient group to determine any differences. Methods: The study consisted of a total of 60 patients. The control group and the study group each included 30 patients. SPEA levels were compared between the groups. Pre- and post-operative SPEA levels were also compared in the patient group. Results: The mean SPEA value was 213.51 U/L pre-operative group and 177.73 U/L post-operative group. The decrease in SPEA levels after the adenotonsillectomy was statistically significant (p < 0.05). When the patient and control groups were compared, SPEA levels in the patient group were statistically significantly higher than in the control group (p < 0.05). The mean SPEA value was 188.87 U/L in the control group, whereas it was 213.51 U/L in the patient group. Conclusions: SPEA levels were significantly higher in ATH patients than in healthy children. SPEA levels were found to decrease significantly after adenotonsillectomy. This finding suggests that SPEA may play a role in the etiopathogenesis of ATH.
- 1 April 2026
- Published by Modestum Ltd in Journal of Clinical and Experimental Investigations
- Vol. 17 (2) , em00859
Investigation of serum prolidase enzyme levels in patients with adenotonsillar hypertrophy
Objective: We investigated serum prolidase enzyme activity (SPEA) in patients with adenotonsillar hypertrophy (ATH) and compared the results with those of healthy children. We determined the enzyme levels again after adenotonsillectomy in the patient group to determine any differences. Methods: The study consisted of a total of 60 patients. The control group and the study group each included 30 patients. SPEA levels were compared between the groups. Pre- and post-operative SPEA levels were also compared in the patient group. Results: The mean SPEA value was 213.51 U/L pre-operative group and 177.73 U/L post-operative group. The decrease in SPEA levels after the adenotonsillectomy was statistically significant (p < 0.05). When the patient and control groups were compared, SPEA levels in the patient group were statistically significantly higher than in the control group (p < 0.05). The mean SPEA value was 188.87 U/L in the control group, whereas it was 213.51 U/L in the patient group. Conclusions: SPEA levels were significantly higher in ATH patients than in healthy children. SPEA levels were found to decrease significantly after adenotonsillectomy. This finding suggests that SPEA may play a role in the etiopathogenesis of ATH.
- Open Access
- 1 August 2021
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 46 (4) , 473-477
The effects of oral steroid therapy on prolidase enzyme activity in patients with nasal polyps
Objective: To compare prolidase enzyme activity (PEA) in serum and polyp specimens of patients with nasal polyps obtained before and after the oral steroid therapy. Materials and methods: Thirty three patients with nasal polyps (39 ± 13 years) received 1 mg/kg of oral steroids. Serum samples were collected from each patient, but nasal polyp specimens could be obtained only from 23 patients (38 ± 13 years) before and after the oral steroid therapy. PEA was measured by ELISA method. Results: Serum PEA values were 210 (176–242) U/L and 184 (147–217) U/L before and after the oral steroid therapy, respectively (p = 0.015). Polyp tissue PEA was 1337 (738–2130) U/g and 871 (590–1663) U/g before and after the oral steroid therapy, respectively (p = 0.429). Conclusion: In patients with nasal polyps, significantly lower serum PEA after the oral steroid therapy may be a consequence of the role of prolidase enzyme in inflammatory processes which are important for the development of nasal polyps. More comprehensive studies with larger sample sizes are needed to elucidate the role of PEA in the pathogenesis of nasal polyps.
- 1 August 2021
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 46 (4) , 473-477
Open AccessThe effects of oral steroid therapy on prolidase enzyme activity in patients with nasal polyps
Objective: To compare prolidase enzyme activity (PEA) in serum and polyp specimens of patients with nasal polyps obtained before and after the oral steroid therapy. Materials and methods: Thirty three patients with nasal polyps (39 ± 13 years) received 1 mg/kg of oral steroids. Serum samples were collected from each patient, but nasal polyp specimens could be obtained only from 23 patients (38 ± 13 years) before and after the oral steroid therapy. PEA was measured by ELISA method. Results: Serum PEA values were 210 (176–242) U/L and 184 (147–217) U/L before and after the oral steroid therapy, respectively (p = 0.015). Polyp tissue PEA was 1337 (738–2130) U/g and 871 (590–1663) U/g before and after the oral steroid therapy, respectively (p = 0.429). Conclusion: In patients with nasal polyps, significantly lower serum PEA after the oral steroid therapy may be a consequence of the role of prolidase enzyme in inflammatory processes which are important for the development of nasal polyps. More comprehensive studies with larger sample sizes are needed to elucidate the role of PEA in the pathogenesis of nasal polyps.
- 28 August 2020
- Published by AVES YAYINCILIK A.Ş. in European Journal of Rhinology and Allergy
- Vol. 3 (2) , 34-38
Comparison of Preoperative and Postoperative Antioxidant Levels in Patients with Adenotonsillar Hypertrophy
Adenotonsillar hypertrophy,total oxidant status,total antioxidant status,oxidative stress ındex,paraoxonase
- 28 August 2020
- Published by AVES YAYINCILIK A.Ş. in European Journal of Rhinology and Allergy
- Vol. 3 (2) , 34-38
Comparison of Preoperative and Postoperative Antioxidant Levels in Patients with Adenotonsillar Hypertrophy
Adenotonsillar hypertrophy,total oxidant status,total antioxidant status,oxidative stress ındex,paraoxonase
- 1 July 2020
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology (Versão em Português)
- Vol. 86 (4) , 405-410
Evaluation of serum prolidase enzyme activity and oxidative stress in patients with tinnitus
- 1 July 2020
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology (Versão em Português)
- Vol. 86 (4) , 405-410
Evaluation of serum prolidase enzyme activity and oxidative stress in patients with tinnitus
- Open Access
- 15 March 2019
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 86 (4) , 405-410
Evaluation of serum prolidase enzyme activity and oxidative stress in patients with tinnitus
- 15 March 2019
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 86 (4) , 405-410
Open AccessEvaluation of serum prolidase enzyme activity and oxidative stress in patients with tinnitus
- 1 October 2018
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 132 (10) , 891-895
The effects of systemic steroid therapy on macrophage migration inhibitory factor concentrations in patients with nasal polyps
Objectives. This study aimed to compare serum macrophage migration inhibitory factor concentrations before and after oral steroid therapy in nasal polyps patients, and determine whether there is a difference between pre-treatment macrophage migration inhibitory factor concentrations and healthy individuals. Methods. The study included 24 patients with nasal polyps and 25 healthy individuals. The patient group received 1 mg/kg oral steroid. Results. The mean macrophage migration inhibitory factor concentration before oral steroid therapy was 3889.79 pg/ml in the patient group and 2334.52 pg/ml in the control group. Macrophage migration inhibitory factor concentrations were statistically significantly higher in the pre-oral steroid therapy patient group than in the control group (p = 0.017). The mean pre- and post-oral steroid therapy serum macrophage migration inhibitory factor concentrations were 3889.79 pg/ml and 2451.25 pg/ml, respectively. The reduction in macrophage migration inhibitory factor concentrations was statistically significant (p = 0.010). Conclusion. These findings suggest that concentrations of macrophage migration inhibitory factor may play a role in the pathogenesis of nasal polyps.
- 1 October 2018
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 132 (10) , 891-895
The effects of systemic steroid therapy on macrophage migration inhibitory factor concentrations in patients with nasal polyps
Objectives. This study aimed to compare serum macrophage migration inhibitory factor concentrations before and after oral steroid therapy in nasal polyps patients, and determine whether there is a difference between pre-treatment macrophage migration inhibitory factor concentrations and healthy individuals. Methods. The study included 24 patients with nasal polyps and 25 healthy individuals. The patient group received 1 mg/kg oral steroid. Results. The mean macrophage migration inhibitory factor concentration before oral steroid therapy was 3889.79 pg/ml in the patient group and 2334.52 pg/ml in the control group. Macrophage migration inhibitory factor concentrations were statistically significantly higher in the pre-oral steroid therapy patient group than in the control group (p = 0.017). The mean pre- and post-oral steroid therapy serum macrophage migration inhibitory factor concentrations were 3889.79 pg/ml and 2451.25 pg/ml, respectively. The reduction in macrophage migration inhibitory factor concentrations was statistically significant (p = 0.010). Conclusion. These findings suggest that concentrations of macrophage migration inhibitory factor may play a role in the pathogenesis of nasal polyps.
- Open Access
- 13 June 2018
- Published by Modestum Ltd in Journal of Clinical and Experimental Investigations
- Vol. 9 (2) , 71-75
Levels of Th1 and Th2 Cytokines in Patients with Nasal Polyps
Objective: We aimed to investigate Th1 / Th2 (T helper) cell balance by examining Interleukin-4 (IL-4), Interleukin-5 (IL-5), Interleukin-10 (IL-10), Interleukin-17 (IL-17) and Interferon gamma (IFN γ) levels in serum in patients with nasal polyps (NPs). Patients and Methods: This study included 45 patients (mean age: 34.8 years) with NPs and a control group (mean age: 37.9) consisting of 45 healthy volunteers. Results: The mean IL-17 level in the NPs group (4.096 pg/ml) was significantly higher than the control group (2.219 pg/ml) (p<0.001). IL-5 levels were significantly higher in the control group. NPs group had significantly lower IL-5 level compared with the control group (1.981 pg/ml vs. 2.720 pg/ml, respectively: p<0.001). The mean IFN γ concentration was significantly lower in the NPs group (0.379 pg/ml) compared to the control group (0.439 pg/ml) (p=0.011). No significant differences were found in the IL-4 (3.25 pg/ml vs. 3.38 pg/ml) and IL-10 (11.249 pg/ml vs. 12.156 pg/ml) concentrations between NPs and the control groups (p=0.799 and p=0.255, respectively). Conclusions: Increased IL-17 levels were found in NPs patients. There was no significant differences in IL-4 and IL-10 values of the Th1 cytokines among the groups, whereas IL-5 was found to be low in the NPs group. IFN gamma values of Th2 cytokines were found to be low in the NPs group. According to these results, low IFN gamma levels and regulatory cytokine IL-7 activation may be effective in the etiopathogenesis of NPs.
- 13 June 2018
- Published by Modestum Ltd in Journal of Clinical and Experimental Investigations
- Vol. 9 (2) , 71-75
Open AccessLevels of Th1 and Th2 Cytokines in Patients with Nasal Polyps
Objective: We aimed to investigate Th1 / Th2 (T helper) cell balance by examining Interleukin-4 (IL-4), Interleukin-5 (IL-5), Interleukin-10 (IL-10), Interleukin-17 (IL-17) and Interferon gamma (IFN γ) levels in serum in patients with nasal polyps (NPs). Patients and Methods: This study included 45 patients (mean age: 34.8 years) with NPs and a control group (mean age: 37.9) consisting of 45 healthy volunteers. Results: The mean IL-17 level in the NPs group (4.096 pg/ml) was significantly higher than the control group (2.219 pg/ml) (p<0.001). IL-5 levels were significantly higher in the control group. NPs group had significantly lower IL-5 level compared with the control group (1.981 pg/ml vs. 2.720 pg/ml, respectively: p<0.001). The mean IFN γ concentration was significantly lower in the NPs group (0.379 pg/ml) compared to the control group (0.439 pg/ml) (p=0.011). No significant differences were found in the IL-4 (3.25 pg/ml vs. 3.38 pg/ml) and IL-10 (11.249 pg/ml vs. 12.156 pg/ml) concentrations between NPs and the control groups (p=0.799 and p=0.255, respectively). Conclusions: Increased IL-17 levels were found in NPs patients. There was no significant differences in IL-4 and IL-10 values of the Th1 cytokines among the groups, whereas IL-5 was found to be low in the NPs group. IFN gamma values of Th2 cytokines were found to be low in the NPs group. According to these results, low IFN gamma levels and regulatory cytokine IL-7 activation may be effective in the etiopathogenesis of NPs.
- Open Access
- 17 March 2018
- Published by Dicle Medical Journal/Dicle Tip Dergisi in Dicle Tıp Dergisi
- Vol. 45 (1) , 1-7
Investigation of serum oxidative stress levels in patients with nasal polyps
Objective: To compare serum total antioxidant status (TAS), total oxidant status (TOS), and paraoxonase (PON1) levels between nasal polyp patients and heal thy subjects.Method: In the present study, The nasal polyp group includes 26 males an 22 females, a total of 48 patients (mean age 37.11±12.07 years), while the control group included 22 males and 24 females, a total of 46 healthy subjects (mean age 36.91±13.03) years. Groups were compared in terms of serum TAS, TOS and PON1 levels. Results: The mean TAS level was 1.248 mmol/L in the control group, it was 1.176 mmol/L in the patient group (p=0.044). The mean TOS level was 3.443 mmol/L in the control group, and it was 6.720 mmol/L in the patient group (p=006). Nasal polyp and control groups did not show any significant difference for PON1 (301.15 U/L vs. 295.75 U/L,p>0.05). Conclusion: Serum TOS levels were significantly higher, and TAS levels were significantly lower in patients with nasal polyposis compared it the control group. There was no significant difference between the patients with nasal polypand the control group in terms of the PON1 values.
- 17 March 2018
- Published by Dicle Medical Journal/Dicle Tip Dergisi in Dicle Tıp Dergisi
- Vol. 45 (1) , 1-7
Open AccessInvestigation of serum oxidative stress levels in patients with nasal polyps
Objective: To compare serum total antioxidant status (TAS), total oxidant status (TOS), and paraoxonase (PON1) levels between nasal polyp patients and heal thy subjects.Method: In the present study, The nasal polyp group includes 26 males an 22 females, a total of 48 patients (mean age 37.11±12.07 years), while the control group included 22 males and 24 females, a total of 46 healthy subjects (mean age 36.91±13.03) years. Groups were compared in terms of serum TAS, TOS and PON1 levels. Results: The mean TAS level was 1.248 mmol/L in the control group, it was 1.176 mmol/L in the patient group (p=0.044). The mean TOS level was 3.443 mmol/L in the control group, and it was 6.720 mmol/L in the patient group (p=006). Nasal polyp and control groups did not show any significant difference for PON1 (301.15 U/L vs. 295.75 U/L,p>0.05). Conclusion: Serum TOS levels were significantly higher, and TAS levels were significantly lower in patients with nasal polyposis compared it the control group. There was no significant difference between the patients with nasal polypand the control group in terms of the PON1 values.
- 1 February 2018
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 105, 79-84
Profilactic role of simvastatin and mitomycin C in tracheal stenosis after tracheal damage: Study in rats
- 1 February 2018
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 105, 79-84
Profilactic role of simvastatin and mitomycin C in tracheal stenosis after tracheal damage: Study in rats
- 29 September 2017
- Published by Galenos Yayinevi in Turkish Archives of Otorhinolaryngology
- Vol. 55 (3) , 125-128
Serum Oxidative Stress Levels in Patients with Nasal Septal Deviation
Türk Otorinolarengoloji Arşivi
- 29 September 2017
- Published by Galenos Yayinevi in Turkish Archives of Otorhinolaryngology
- Vol. 55 (3) , 125-128
Serum Oxidative Stress Levels in Patients with Nasal Septal Deviation
Türk Otorinolarengoloji Arşivi